微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 42.06% | -4.79% | -2.94% | 87/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 43.34% | -3.78% | -6.67% | 90/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 46.43% | 3.7% | 3.79% | 83/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 44.74% | 0.46% | 1.26% | 84/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 44.18% | -1.38% | -1.9% | 84/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 45.04% | -0.07% | 0.58% | 84/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 44.78% | -4.72% | 0.55% | 81/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 44.53% | -2.96% | -0.59% | 87/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 44.8% | -1.31% | -0.6% | 84/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 45.07% | -1.9% | -4.1% | 86/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 47% | 4.3% | 2.42% | 80/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 45.89% | 6.24% | 1.09% | 86/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 45.39% | 5.16% | -1.2% | 83/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 45.94% | 8.32% | 1.96% | 84/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 45.06% | 8.6% | 4.33% | 83/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 43.19% | 1.96% | 0.06% | 91/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 43.17% | 0.6% | 1.77% | 84/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 42.41% | -0.54% | 2.22% | 90/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 41.49% | -2.45% | -2.05% | 84/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 42.36% | -3.18% | -1.28% | 101/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 42.91% | -3.1% | 0.62% | 87/142 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 42.65% | -3.02% | 0.26% | 95/142 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 42.54% | 0.89% | -2.79% | 81/142 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 43.75% | -1.11% | -1.19% | 100/142 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 44.28% | 1.71% | 0.7% | 71/142 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 43.97% | 2.25% | 4.3% | 89/142 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 42.16% | 0.92% | -4.71% | 58/142 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 44.25% | 25.81% | 1.63% | 85/142 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 43.54% | 32.59% | 1.23% | 46/142 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 43.01% | 32.56% | 2.94% | 55/142 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 41.78% | 26.5% | 18.79% | 34/142 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 35.17% | 2.99% | 7.11% | 90/142 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 32.83% | -6.17% | 1.21% | 43/142 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 32.44% | -11.44% | -1.76% | 50/142 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 33.03% | -9.15% | -3.29% | 41/142 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 34.15% | -8.7% | -2.42% | 85/142 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 34.99% | -4.61% | -4.48% | 37/142 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 36.64% | 0.48% | 0.78% | 46/142 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 36.35% | -3.43% | -2.8% | 35/142 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 37.4% | 11.89% | 1.95% | 63/142 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 36.69% | 10.25% | 0.62% | 31/142 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 36.46% | 11.6% | -3.15% | 38/142 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 37.64% | 2.42% | 12.62% | 26/142 | 50.24% | 健帆生物 | 83.86% | 行业排名> |